RE: BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis
- PMID: 30715414
- PMCID: PMC6510222
- DOI: 10.1093/jnci/djz012
RE: BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis
Comment in
-
Response to Katona et al.J Natl Cancer Inst. 2019 May 1;111(5):524-525. doi: 10.1093/jnci/djz013. J Natl Cancer Inst. 2019. PMID: 30715401 No abstract available.
Comment on
-
BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.J Natl Cancer Inst. 2018 Nov 1;110(11):1178-1189. doi: 10.1093/jnci/djy148. J Natl Cancer Inst. 2018. PMID: 30380096
References
-
- Oh M, McBride A, Yun S, et al. BRCA1 and BRCA2 gene mutations and colorectal cancer risk: systematic review and meta-analysis. J Natl Cancer Inst. 2018;110(11):1178–1189. - PubMed
-
- Locker GY, Lynch HT.. Genetic factors and colorectal cancer in Ashkenazi Jews. Fam Cancer. 2004;3(3–4):215–221. - PubMed
-
- Johns LE, Houlston RS.. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96(10):2992–3003. - PubMed
-
- Katona BW, Yurgelun MB, Garber JE, et al. A counseling framework for moderate-penetrance colorectal cancer susceptibility genes. Genet Med. 2018; 20(11): 1324–1327. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
